Status:
COMPLETED
Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion
Lead Sponsor:
Gynuity Health Projects
Conditions:
Termination of Pregnancy
Eligibility:
FEMALE
18-55 years
Phase:
NA
Brief Summary
The primary aim of this study is to assess the acceptability of home-use mifepristone for termination of pregnancy among women who choose it and their providers. The investigators' secondary aims are ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Reproductive age women seeking abortion services.
- Eligible women will be in general good health and assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken.
- Participants must be eligible for medical abortion according to clinician and clinic standards.
- In the United States, women only 18 years and older will be eligible to participate, unless the study site obtains a waiver to include minors.
Exclusion
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
615 Patients enrolled
Trial Details
Trial ID
NCT00994734
Start Date
May 1 2009
End Date
February 1 2011
Last Update
April 17 2012
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Feminist Women's Health Center
Atlanta, Georgia, United States
2
Institute for Family Health
New York, New York, United States
3
Family Health Center, Montefiore Medical Center
The Bronx, New York, United States
4
University of Pennsylvania
Philadelphia, Pennsylvania, United States